121 related articles for article (PubMed ID: 36152023)
1. Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer.
Osterlund E; Glimelius B
Acta Oncol; 2022 Oct; 61(10):1278-1288. PubMed ID: 36152023
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
3. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.
Reboux N; Jooste V; Goungounga J; Robaszkiewicz M; Nousbaum JB; Bouvier AM
JAMA Netw Open; 2022 Oct; 5(10):e2236666. PubMed ID: 36239935
[TBL] [Abstract][Full Text] [Related]
5. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
[TBL] [Abstract][Full Text] [Related]
6. Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Benavides M; Gómez-España A; García-Alfonso P; González CG; Viéitez JM; Rivera F; Safont MJ; Abad A; Sastre J; Valladares-Ayerbes M; Carrato A; González-Flores E; Robles L; Salud A; Alonso-Orduña V; Montagut C; Asensio E; Díaz-Rubio E; Aranda E;
Eur J Surg Oncol; 2022 May; 48(5):1123-1132. PubMed ID: 34872775
[TBL] [Abstract][Full Text] [Related]
7. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer.
Ljunggren M; Weibull CE; Palmer G; Osterlund E; Glimelius B; Martling A; Nordenvall C
Int J Cancer; 2023 Feb; 152(3):363-373. PubMed ID: 36000990
[TBL] [Abstract][Full Text] [Related]
9. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
[TBL] [Abstract][Full Text] [Related]
11. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.
Rose JS; Serna DS; Martin LK; Li X; Weatherby LM; Abdel-Misih S; Zhao W; Bekaii-Saab T
Cancer; 2012 Dec; 118(24):6243-52. PubMed ID: 22674181
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
13. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
Suthananthan AE; Bhandari M; Platell C
ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
[TBL] [Abstract][Full Text] [Related]
14. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.
Engstrand J; Strömberg C; Nilsson H; Freedman J; Jonas E
World J Surg Oncol; 2019 Dec; 17(1):228. PubMed ID: 31878952
[TBL] [Abstract][Full Text] [Related]
15. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.
Segelman J; Granath F; Holm T; Machado M; Mahteme H; Martling A
Br J Surg; 2012 May; 99(5):699-705. PubMed ID: 22287157
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features and prognosis of synchronous and metachronous multiple primary colorectal cancer.
Zhang C; Cui M; Xing J; Yang H; Yao Z; Zhang N; Su X
Clin Transl Oncol; 2021 Feb; 23(2):335-343. PubMed ID: 32592156
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease.
Tan EK; Ooi LL
Ann Acad Med Singap; 2010 Sep; 39(9):719-15. PubMed ID: 20957308
[TBL] [Abstract][Full Text] [Related]
18. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
[TBL] [Abstract][Full Text] [Related]
20. Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysis.
van der Kruijssen DEW; van der Kuil AJS; Vink GR; Punt CJA; de Wilt JHW; Elias SG; Koopman M
Int J Cancer; 2023 Apr; 152(7):1360-1369. PubMed ID: 36346099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]